Low toxic agents for treatment of B-Cell Lymphomas and Leishmaniasis
Search for novel natural products from the extracts of various parts of plants is still an important pillar of modern drug research. Plants of the families Dioncophyllaceae and Ancistrocladaceae are the only producers of Naphtho¬quinones. These novel lead candidates can be used as antitumoral agents for the treatment of B-cell lymphoma or multiple myeloma and as antiinfectives against malaria, African sleeping sickness, Chagas disease or leishma¬niasis.
<p> The novel lead substances can be used as antitumoral agents for the treatment of B-cell lymphoma or multiple myeloma. In vitro tests prove significantly reduced cell poliferation in tumor cell lines of aggressive B-Cell lymphomas as well as MM whereas they are non-toxic against normal peripheralmono-nuclear blood cells. <p> The compounds are attractive leads for the treatment of multiple myeloma which is the second most frequent hematological form of tumor and offer an alternative to the anti-CD20 treatment strategies. <p>
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Security vulnerability in browser interface
… allows computer access via graphics card. Researchers at Graz University of Technology were successful with three different side-channel attacks on graphics cards via the WebGPU browser interface. The attacks…
A closer look at mechanochemistry
Ferdi Schüth and his team at the Max Planck Institut für Kohlenforschung in Mülheim/Germany have been studying the phenomena of mechanochemistry for several years. But what actually happens at the…
Severe Vulnerabilities Discovered in Software to Protect Internet Routing
A research team from the National Research Center for Applied Cybersecurity ATHENE led by Prof. Dr. Haya Schulmann has uncovered 18 vulnerabilities in crucial software components of Resource Public Key…
